These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25547938)

  • 1. A new, intriguing hypothesis: does bivalirudin reduce the risk of acute kidney disease?
    Cortese B; Sciahbasi A; Rigattieri S; Ricci R
    Am J Cardiol; 2015 Feb; 115(4):555-6. PubMed ID: 25547938
    [No Abstract]   [Full Text] [Related]  

  • 2. About acute kidney injury during primary percutaneous coronary intervention.
    Zingarelli A
    Am J Cardiol; 2015 Jan; 115(2):279. PubMed ID: 25465926
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of risk of acute kidney injury after primary percutaneous coronary interventions with the transradial approach versus the transfemoral approach (from the PRIPITENA urban registry).
    Cortese B; Sciahbasi A; Sebik R; Rigattieri S; Alonzo A; Silva-Orrego P; Belloni F; Seregni RG; Giovannelli F; Tespili M; Ricci R; Berni A
    Am J Cardiol; 2014 Sep; 114(6):820-5. PubMed ID: 25073568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Propensity Score-Matched Analysis of Acute Kidney Injury After Percutaneous Coronary Intervention With Transradial Versus Transfemoral Approaches.
    Steinvil A; Garcia-Garcia HM; Rogers T; Koifman E; Buchanan K; Alraies MC; Torguson R; Pichard AD; Satler LF; Ben-Dor I; Waksman R
    Am J Cardiol; 2017 May; 119(10):1507-1511. PubMed ID: 28341354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vascular access on acute kidney injury after percutaneous coronary intervention.
    Andò G; Costa F; Trio O; Oreto G; Valgimigli M
    Cardiovasc Revasc Med; 2016; 17(5):333-8. PubMed ID: 27050627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ACEF score as predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Int J Cardiol; 2013 Oct; 168(4):4386-7. PubMed ID: 23711447
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials.
    Warren J; Mehran R; Baber U; Xu K; Giacoppo D; Gersh BJ; Guagliumi G; Witzenbichler B; Magnus Ohman E; Pocock SJ; Stone GW
    Am Heart J; 2016 Jan; 171(1):40-7. PubMed ID: 26699599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction.
    Khera S; Kolte D; Aronow WS; Palaniswamy C; Mujib M; Ahmed A; Chugh SS; Balasubramaniyam N; Edupuganti M; Frishman WH; Fonarow GC
    Am J Cardiol; 2013 Nov; 112(9):1279-86. PubMed ID: 23866733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.
    Parashar A; Agarwal S; Krishnaswamy A; Sud K; Poddar KL; Bassi M; Ellis S; Tuzcu EM; Menon V; Kapadia SR
    J Am Coll Cardiol; 2016 Jul; 68(4):329-38. PubMed ID: 27443427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of early acute kidney injury after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kim JH; Lee JH; Jang SY; Park SH; Bae MH; Yang DH; Park HS; Cho Y; Chae SC
    Am J Cardiol; 2014 Oct; 114(8):1174-8. PubMed ID: 25159240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous intervention for chronic total occlusion: integrating strategies to address an unmet need.
    Smith EJ; Strange JW; Hanratty CG; Walsh SJ; Spratt JC
    Heart; 2013 Oct; 99(20):1471-4. PubMed ID: 23899783
    [No Abstract]   [Full Text] [Related]  

  • 14. ADVANCIS Score Predicts Acute Kidney Injury After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Fan PC; Chen TH; Lee CC; Tsai TY; Chen YC; Chang CH
    Int J Med Sci; 2018; 15(5):528-535. PubMed ID: 29559842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Access Site Choice on Acute Kidney Injury After Percutaneous Coronary Intervention.
    Pancholy MS; Skelding K; Scott T; Blankenship J; Pancholy SB
    Am J Cardiol; 2017 Dec; 120(12):2141-2145. PubMed ID: 29100589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction.
    Dauerman HL; Frederick PD; Miller D; French WJ;
    Coron Artery Dis; 2007 Mar; 18(2):141-8. PubMed ID: 17301606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.
    Vora AN; Peterson ED; McCoy LA; Garratt KN; Kutcher MA; Marso SP; Roe MT; Messenger JC; Rao SV
    JACC Cardiovasc Interv; 2016 Apr; 9(8):771-779. PubMed ID: 27101904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.
    Patel JH; Gupta R; Roe MT; Peng SA; Wiviott SD; Saucedo JF
    Am J Cardiol; 2014 Jan; 113(2):256-61. PubMed ID: 24290492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.